Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD

Bone Marrow Transplantation
A ImS Z Pavletic

Abstract

Although fatigue is common after allogeneic hematopoietic cell transplantation, little is known about fatigue in patients with chronic GvHD (cGvHD). The aim of this study was to explore factors associated with fatigue in cGvHD. Data were drawn from a sequentially recruited, cross-sectional study of adults with moderate or severe cGvHD (n=263). Respondents were classified as fatigued or not fatigued based on their response to a single item regarding loss of energy from the Lee cGvHD Symptom Scale. In univariate analysis, factors significantly associated with fatigue included performance status, number of prior cGvHD therapies, cGvHD symptom bother, self-assessed physical and mental health, nutritional status, walk velocity and self-reported physical activity. There were no significant associations between fatigue and disease-related cGvHD variables. Multivariable logistic regression demonstrated that being less active and having pulmonary and/or muscle/joint symptoms were independently associated with fatigue. In conclusion, clinically significant fatigue was prevalent in more than one-third of subjects with cGvHD, and was disabling. Absence of association with measures of cGvHD severity underscores the need to elucidate the pat...Continue Reading

References

May 29, 1993·BMJ : British Medical Journal·C JenkinsonL Wright
Jan 31, 1998·Bone Marrow Transplantation·M A AndrykowskiP J Henslee-Downey
Sep 11, 1998·Bone Marrow Transplantation·C S NeitzertJ Avery
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S J LeeJ C Weeks
Dec 1, 2001·Journal of Pain and Symptom Management·K L KirshD Theobald
Feb 23, 2002·Bone Marrow Transplantation·D A JacobsohnG B Vogelsang
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T L KissH A Messner
Sep 18, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie k LeeJoseph H Antin
Apr 30, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie J LeeMary E D Flowers
Jun 19, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie J LeeJane C Weeks
May 20, 2004·JAMA : the Journal of the American Medical Association·Karen L SyrjalaPaul J Martin
Aug 19, 2004·Neuroimmunomodulation·Bang-Ning LeeCharles S Cleeland
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A AndrykowskiJohn R Wingard
Nov 30, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jesús M PrietoCristobal Gastó
Dec 13, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Alexandra H FilipovichMary E D Flowers
Oct 21, 2006·Current Opinion in Hematology·Kristin Baird, Steven Z Pavletic
Dec 21, 2006·Brain, Behavior, and Immunity·Christian SchubertJoel E Dimsdale
Feb 1, 2007·Clinical Rehabilitation·Megan Davidson, Natalie de Morton
Mar 21, 2007·Bone Marrow Transplantation·M F M GielissenG Bleijenberg
Aug 1, 2007·The Oncologist·Julie L RyanGary R Morrow
May 23, 2008·Journal of Pain and Symptom Management·Kristine A DonovanMichael A Andrykowski
Sep 1, 2004·Journal of the National Comprehensive Cancer Network : JNCCN·Joseph A RoscoeAbhay R Shelke
Feb 11, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Barbara DeschlerJürgen Finke
Mar 17, 2010·Bone Marrow Transplantation·S PalluaB Holzner
Jul 28, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Catherine E MosherWilliam H Redd
Apr 12, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Linda F BrownJingwei Wu
Apr 27, 2012·British Journal of Haematology·Fiona L DignanUNKNOWN British Society for Blood and Marrow Transplantation
Apr 27, 2012·British Journal of Haematology·Fiona L DignanUNKNOWN British Society for Blood and Marrow Transplantation
Jul 11, 2012·Brain, Behavior, and Immunity·Julienne E Bower, Donald M Lamkin
Jul 23, 2013·Bone Marrow Transplantation·J PidalaS J Lee
Dec 21, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Margaret F BevansLi Yang
Mar 29, 2014·European Journal of Haematology·Annemieke LeunisBob Löwenberg
Jul 6, 2014·Internal Medicine Journal·R ZordanJ Philip

❮ Previous
Next ❯

Citations

Jan 18, 2018·Bone Marrow Transplantation·Mohamad Baydoun, Debra L Barton
Aug 24, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jumin ParkMargaret F Bevans
Jun 21, 2020·International Journal of Environmental Research and Public Health·Annika KischAnna Forsberg
Sep 1, 2020·Expert Review of Hematology·Marcell CsanádiJonas Mattsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.